Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
Saved in:
| Title: | Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. |
|---|---|
| Authors: | Gengenbacher M; Department of Rheumatology and Clinical Immunology/Allergology, University Hospital Inselspital Bern, University of Bern, Bern, Switzerland., Sebald HJ, Villiger PM, Hofstetter W, Seitz M |
| Source: | Annals of the rheumatic diseases [Ann Rheum Dis] 2008 May; Vol. 67 (5), pp. 620-4. Date of Electronic Publication: 2007 Aug 24. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
